Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY – Get Free Report)’s stock price reached a new 52-week high on Monday . The company traded as high as $56.50 and last traded at $56.42, with a volume of 4406 shares changing hands. The stock had previously closed at $55.94.
Analyst Upgrades and Downgrades
Separately, Royal Bank Of Canada raised shares of Sandoz Group from a “hold” rating to a “moderate buy” rating in a research report on Friday, May 2nd.
Read Our Latest Stock Report on Sandoz Group
Sandoz Group Price Performance
Sandoz Group Company Profile
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
Read More
- Five stocks we like better than Sandoz Group
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- 5 Robotics Stocks to Buy for the Future of Automation
- Comparing and Trading High PE Ratio Stocks
- Joby vs. Archer: Which eVTOL Stock Is Better for Your Portfolio?
- 3 Monster Growth Stocks to Buy Now
- 3 Infrastructure Stocks Riding the U.S. Building Boom
Receive News & Ratings for Sandoz Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sandoz Group and related companies with MarketBeat.com's FREE daily email newsletter.
